This is further demonstrated in the current study by the concordant decrease of CD8+ TNAIVE and CD8+CD127+ cells along with the increase of CD8+TE, CD8+CD28− and CD8+CD57+ cells in patients with CKD stage 3. This evidence concerns the gene B3GAT1 and chronic kidney disease.